|
|
|
Insider
Information: |
Jaeger Wilfred E |
Relationship: |
Director |
City: |
Portola Valley |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
200,655 |
|
Indirect Shares
|
6,921,311 |
|
|
Direct
Value |
$387,237 |
|
|
Indirect Value
|
$538,186 |
|
|
Total
Shares |
7,121,966 |
|
|
Total
Value |
$925,422 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
North American Scientific Inc |
NASMQ |
Director |
|
0 |
2006-06-14 |
5,121,638 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
Director |
2015-11-24 |
52,500 |
2014-01-16 |
0 |
Premium* |
|
Epocrates Inc |
EPOC |
Former 10% Owner |
2011-02-07 |
0 |
2011-02-07 |
1,655,329 |
Premium* |
|
Liposcience Inc |
LPDX |
10% Owner |
|
0 |
2013-01-30 |
83,739 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2014-11-18 |
29,052 |
Premium* |
|
Nevro Corp |
NVRO |
Director |
2020-05-21 |
9,592 |
2020-05-21 |
31,553 |
Premium* |
|
Neuronetics Inc |
STIM |
Director |
2023-05-25 |
138,563 |
2018-07-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2014-02-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,663 |
|
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2014-11-18 |
4 |
S |
$12.29 |
$3,072,500 |
I/I |
(250,000) |
29,052 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2021-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
5,125 |
5,125 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2022-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,400 |
21,525 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,125) |
0 |
0 |
- |
|
CNCE |
Concert Pharmaceuticals, ... |
Director |
|
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,400) |
0 |
0 |
- |
|
EPOC |
Epocrates Inc |
Former 10% Owner |
|
2011-02-07 |
4 |
S |
$16.00 |
$4,673,856 |
I/I |
(292,116) |
1,655,329 |
0 |
- |
|
EPOC |
Epocrates Inc |
Former 10% Owner |
|
2011-02-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,947,445 |
1,947,445 |
0 |
- |
|
LPDX |
Liposcience Inc |
10% Owner |
|
2013-01-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
30,752 |
|
- |
|
LPDX |
Liposcience Inc |
10% Owner |
|
2013-01-30 |
4 |
B |
$9.00 |
$1,935,000 |
I/I |
215,000 |
83,739 |
1.5 |
- |
|
LPDX |
Liposcience Inc |
10% Owner |
|
2013-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,609,334 |
74,034 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2008-08-29 |
4 |
B |
$2.04 |
$1,999,998 |
I/I |
980,391 |
70,764 |
2.1 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2009-10-05 |
4 |
B |
$1.86 |
$1,947,643 |
I/I |
1,047,120 |
124,188 |
2.25 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-07-13 |
4 |
S |
$8.01 |
$1,001,662 |
I/I |
(125,000) |
117,810 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-08-09 |
4 |
OE |
$1.86 |
$1,588,047 |
I/I |
811,003 |
159,186 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-08-21 |
4 |
S |
$7.50 |
$225,000 |
I/I |
(30,000) |
157,655 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-08-22 |
4 |
S |
$7.52 |
$447,966 |
I/I |
(59,600) |
154,665 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-08-24 |
4 |
S |
$8.02 |
$4,011,150 |
I/I |
(500,000) |
129,155 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-08-27 |
4 |
S |
$7.98 |
$2,284,727 |
I/I |
(286,400) |
114,543 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2012-09-04 |
4 |
OE |
$0.79 |
$81,150 |
D/D |
55,000 |
55,000 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-06-07 |
4 |
S |
$5.47 |
$546,710 |
I/I |
(100,000) |
109,441 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-06-10 |
4 |
S |
$5.50 |
$294,816 |
I/I |
(53,600) |
106,706 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-06-17 |
4 |
S |
$5.53 |
$294,158 |
I/I |
(53,222) |
103,991 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-06-18 |
4 |
S |
$5.50 |
$393,411 |
I/I |
(71,511) |
100,342 |
0 |
- |
|
MTEM |
Molecular Templates, Inc. |
Director |
|
2013-06-19 |
4 |
S |
$5.50 |
$11,007 |
I/I |
(2,000) |
100,240 |
0 |
- |
|
87 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|